ADMA Biologics ADMA Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ADMA Biologics's shares (diluted)?
- ADMA Biologics (ADMA) reported shares (diluted) of 240M in Q1 2026.
- How has ADMA Biologics's shares (diluted) changed year-over-year?
- ADMA Biologics's shares (diluted) decreased by 1.9% year-over-year, from 244.7M to 240M.
- What is the long-term trend for ADMA Biologics's shares (diluted)?
- Over 4 years (2021 to 2025), ADMA Biologics's shares (diluted) has grown at a 17.5% compound annual growth rate (CAGR), from 516.4M to 982.9M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.